US › Healthcare

Neogen Corporation (NEOG)

US · Healthcare · Medical Devices

$11.81-0.76%
Last close · 2026-08-04

Latest quarter · ended 2026-05-31

Revenue
$225.3M
Revenue YoY
-0.1%
Net profit
$-11.3M
Profit YoY
+98.2%
EPS
$0.08
EPS estimate
$0.03
Net margin
-5.0%

EPS came in at 0.08 against a street estimate of 0.03 — a beat of 166.7%.

Key statistics

Market cap
$2.63B
Forward P/E
16.0
P/B
1.25
Book value
$9.66
EPS (TTM)
$-0.04
52-week high
$12.85
52-week low
$4.62
50-day MA
$9.42
200-day MA
$8.67
Beta
1.79

Analyst view

Analysts rate Neogen Corporation a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $13.00.

Shareholding

Insiders
0.95%
Institutions
113.95%

Largest institutional holders

FundStake
BlackRock Inc14.96%
Vanguard Portfolio Management, LLC5.88%
T. Rowe Price Investment Management,Inc.4.66%
Vanguard Capital Management, LLC4.39%
Dimensional Fund Advisors, Inc.4.19%
ING Groep NV4.08%
State Street Corp3.94%
Mackenzie Investments3.58%

Recent filings & reports

DocumentDate
Annual report FY20262026-07-30
Results announced · Q3 20262026-07-30
Reg FD disclosure · Q2 20262026-04-20
Quarterly report · Q1 20262026-04-09
Results announced · Q2 20262026-04-09
Board / officer change · Q1 20262026-03-30
Quarterly report · Q4 20252026-01-08
Quarterly report · Q3 20252025-10-09

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Neogen Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.